Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Mechanisms of Diuron-Induced Acute Renal Injury Revealed by

    2026-04-22

    Mechanisms of Diuron-Induced Acute Renal Injury Revealed by Network Toxicology

    Study Background and Research Question

    Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) is a phenylurea herbicide extensively deployed in agricultural and industrial landscapes to inhibit weed growth by disrupting photosynthetic electron transport in plants. Its role as a photosynthesis inhibitor is well-documented, but the compound’s environmental persistence and bioaccumulation have raised critical questions about its broader impact on ecological systems and human health (source: paper). While previous research has characterized its hepatic and reproductive toxicities, Diuron’s nephrotoxic potential—especially its link to acute kidney injury (AKI)—remained insufficiently delineated. The current study addresses this gap by systematically investigating the molecular mechanisms of Diuron-induced AKI, integrating computational and experimental approaches.

    Key Innovation from the Reference Study

    The primary innovation lies in the comprehensive, multi-layered methodology combining network toxicology, molecular docking, transcriptomics, and in vitro validation. This allowed the researchers to map the interface between Diuron exposure and kidney injury at the systems level, culminating in the identification of the JAK2/STAT1 signaling axis as a principal mediator of nephrotoxicity. Such integration surpasses previous studies that typically focused on isolated endpoints or single pathways, offering a holistic view of Diuron’s toxicodynamic profile (source: paper).

    Methods and Experimental Design Insights

    The study’s workflow started with network toxicology analysis, leveraging publicly available datasets to identify overlapping molecular targets between Diuron and AKI. Protein-protein interaction (PPI) networks were constructed, and core targets were pinpointed using topological algorithms. Key hub genes identified included JAK2, STAT1, EGFR, NFKB1, and PARP1. Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis indicated significant involvement of the JAK-STAT pathway and cancer-related signaling. Gene expression was validated using the GSE145085 transcriptomic dataset and quantitative PCR (qPCR). Molecular docking assessed the binding stability between Diuron and the core proteins, confirming plausible direct interactions. Finally, in vitro experiments were performed in human HK-2 proximal tubular cells to assess changes in viability, proliferation, migration, and pathway activation in response to Diuron exposure (source: paper).

    Protocol Parameters

    • assay | Diuron dose-response in HK-2 cell viability | typical range: 1–100 μM | applicability: nephrotoxicity screening | rationale: covers environmentally relevant and cytotoxic concentrations | paper
    • assay | Molecular docking (binding affinity) | −6.5 to −8.7 kcal/mol | applicability: in silico target engagement | rationale: predicts stable ligand–protein interactions | paper
    • assay | qPCR gene expression validation | expression fold-change (≥2) | applicability: mechanistic confirmation | rationale: supports transcriptomic findings | paper
    • assay | DMSO as solvent for Diuron | max 0.1% v/v | applicability: solubilization protocol | rationale: prevents solvent-induced cytotoxicity | workflow_recommendation
    • assay | Storage of Diuron stock solution | −20°C, avoid repeated freeze–thaw | applicability: chemical stability | rationale: maintains compound integrity for reproducible assays | product_spec

    Core Findings and Why They Matter

    Among 149 genes intersecting Diuron and AKI molecular signatures, the JAK2/STAT1 pathway stood out both in silico and in vitro. Functional validation demonstrated that Diuron exposure led to:

    • Significant reduction in HK-2 cell viability, proliferation, and migration in a dose-dependent manner (source: paper).
    • Increased phosphorylation and activation of JAK2 and STAT1, implicating this axis as a driver of Diuron-induced renal cytotoxicity.
    • Stable molecular docking between Diuron and JAK2/STAT1 proteins, supporting a direct mechanistic link.

    These findings provide not only molecular evidence for Diuron’s nephrotoxicity but also a rational basis for monitoring the JAK-STAT pathway as a biomarker or target in environmental toxicology and risk assessment frameworks.

    Comparison with Existing Internal Articles

    Several internal resources discuss Diuron’s role as a photosynthesis inhibitor and benchmark herbicide research chemical:

    • Mechanistic Insights and Toxicology: Summarizes Diuron’s established nephrotoxic risks and laboratory parameters but does not integrate network toxicology or transcriptomic data. The current reference study extends this by pinpointing specific molecular pathways (JAK2/STAT1) and offering multi-modal validation.
    • Environmental Toxicology Applications: Focuses on Diuron’s use in plant biology and environmental studies, emphasizing its inhibition of photosystem II. The present research bridges this knowledge to mammalian systems, highlighting the translational significance of environmental exposures for human health.
    • Applied Workflows: Provides workflow recommendations for Diuron handling and assay set-up, which align with the experimental protocols validated in the reference study.

    Collectively, these resources establish Diuron as a versatile tool in both plant biology and toxicology, with the reference study uniquely advancing our understanding of its impact on mammalian renal systems.

    Limitations and Transferability

    While the study offers a robust mechanistic framework, several limitations should be noted:

    • Cellular Model: In vitro findings in HK-2 cells may not fully recapitulate the complexity of in vivo renal responses or inter-individual variability in human populations.
    • Exposure Window: The acute exposure paradigm does not address chronic, low-dose environmental exposure scenarios relevant to real-world settings.
    • Pathway Specificity: Other signaling networks implicated in AKI were not exhaustively explored, so the full spectrum of Diuron’s nephrotoxic mechanisms remains to be mapped.

    Nevertheless, the integration of computational and experimental data strengthens the case for further translational and epidemiological studies (source: paper).

    Research Support Resources

    For researchers aiming to replicate or extend these findings, high-purity Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) is available from APExBIO (SKU C6731), with validated solubility and stability parameters suitable for toxicological and plant biology research (source: product_spec). Internal protocols and troubleshooting for Diuron-based assays can be found in recent workflow articles (resource). Researchers are advised to follow recommended handling and storage practices to preserve compound integrity and reproducibility.